Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence

Robin Boltjes,Stephanie Knippenberg,Oliver Gerlach,Raymond Hupperts,Jan Damoiseaux

DOI: https://doi.org/10.1080/14737175.2021.1935878

IF: 4.287

2021-06-03

Expert Review of Neurotherapeutics

Abstract:<span>Vitamin D has long been known for its immune-modulating effects, next to its function in calcium metabolism. As a consequence, poor vitamin D status has been associated with many diseases including multiple sclerosis (MS). Epidemiological studies suggest an association between a poor vitamin D status and development of MS and a poor vitamin D status is associated with more relapses and faster progression after patients are diagnosed with MS.The aim of the authors was to review the role of vitamin D supplementation in the treatment of MS. Pubmed was used to review literature with a focus of vitamin D supplementation trials and meta-analyses in MS.There is no solid evidence to support the application of vitamin D therapy, based on current available supplementation trials, although there are some promising results in the clinically isolated syndrome (CIS) patients and young MS patients early after initial diagnosis. The authors recommend further larger clinical trials with selected patient groups, preferable CIS patients and young patients at the time of diagnosis, using vitamin D₃ supplements to reach a 100 nmol/l level, to further investigate the effects of vitamin D supplementation in MS.</span>

pharmacology & pharmacy,clinical neurology